These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37941514)

  • 41. Dopamine Inhibition Differentially Controls Excitability of Substantia Nigra Dopamine Neuron Subpopulations through T-Type Calcium Channels.
    Evans RC; Zhu M; Khaliq ZM
    J Neurosci; 2017 Mar; 37(13):3704-3720. PubMed ID: 28264982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of alpha-synuclein in the development of the dopaminergic neurons in the substantia nigra and ventral tegmental area.
    Tarasova TV; Lytkina OA; Roman AY; Bachurin SO; Ustyugov AA
    Dokl Biol Sci; 2016; 466():5-7. PubMed ID: 27021360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nifedipine and nimodipine protect dopaminergic substantia nigra neurons against axotomy-induced cell death in rat vibrosections via modulating inflammatory responses.
    Daschil N; Humpel C
    Brain Res; 2014 Sep; 1581():1-11. PubMed ID: 25038562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morpho-Functional Changes of Nigral Dopamine Neurons in an α-Synuclein Model of Parkinson's Disease.
    Ledonne A; Massaro Cenere M; Paldino E; D'Angelo V; D'Addario SL; Casadei N; Nobili A; Berretta N; Fusco FR; Ventura R; Sancesario G; Guatteo E; Mercuri NB
    Mov Disord; 2023 Feb; 38(2):256-266. PubMed ID: 36350188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Developmental exposure to the Parkinson's disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected mice.
    Boyd SL; Kuhn NC; Patterson JR; Stoll AC; Zimmerman SA; Kolanowski MR; Neubecker JJ; Luk KC; Ramsson ES; Sortwell CE; Bernstein AI
    Toxicol Sci; 2023 Oct; 196(1):99-111. PubMed ID: 37607008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
    Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW
    J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
    Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
    Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice.
    Ninkina N; Tarasova TV; Chaprov KD; Roman AY; Kukharsky MS; Kolik LG; Ovchinnikov R; Ustyugov AA; Durnev AD; Buchman VL
    Neurobiol Aging; 2020 Jul; 91():76-87. PubMed ID: 32224067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are striatal tyrosine hydroxylase interneurons dopaminergic?
    Xenias HS; Ibáñez-Sandoval O; Koós T; Tepper JM
    J Neurosci; 2015 Apr; 35(16):6584-99. PubMed ID: 25904808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
    Ahlers-Dannen KE; Spicer MM; Fisher RA
    Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aldehyde dehydrogenase 1-positive nigrostriatal dopaminergic fibers exhibit distinct projection pattern and dopamine release dynamics at mouse dorsal striatum.
    Sgobio C; Wu J; Zheng W; Chen X; Pan J; Salinas AG; Davis MI; Lovinger DM; Cai H
    Sci Rep; 2017 Jul; 7(1):5283. PubMed ID: 28706191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopamine and α-synuclein dysfunction in Smad3 null mice.
    Tapia-González S; Giráldez-Pérez RM; Cuartero MI; Casarejos MJ; Mena MÁ; Wang XF; Sánchez-Capelo A
    Mol Neurodegener; 2011 Oct; 6():72. PubMed ID: 21995845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Striatal dopamine neurotransmission is altered in age- and region-specific manner in a Parkinson's disease transgenic mouse.
    Medina-Luque J; Piechocinski P; Feyen P; Sgobio C; Herms J
    Sci Rep; 2024 Jan; 14(1):164. PubMed ID: 38167878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of L-Type Ca
    Sun Y; Zhang H; Selvaraj S; Sukumaran P; Lei S; Birnbaumer L; Singh BB
    J Neurosci; 2017 Mar; 37(12):3364-3377. PubMed ID: 28258168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease.
    Chan CS; Gertler TS; Surmeier DJ
    Mov Disord; 2010; 25 Suppl 1():S63-70. PubMed ID: 20187241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sox6 expression distinguishes dorsally and ventrally biased dopamine neurons in the substantia nigra with distinctive properties and embryonic origins.
    Pereira Luppi M; Azcorra M; Caronia-Brown G; Poulin JF; Gaertner Z; Gatica S; Moreno-Ramos OA; Nouri N; Dubois M; Ma YC; Ramakrishnan C; Fenno L; Kim YS; Deisseroth K; Cicchetti F; Dombeck DA; Awatramani R
    Cell Rep; 2021 Nov; 37(6):109975. PubMed ID: 34758317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exercise in an animal model of Parkinson's disease: Motor recovery but not restoration of the nigrostriatal pathway.
    Churchill MJ; Pflibsen L; Sconce MD; Moore C; Kim K; Meshul CK
    Neuroscience; 2017 Sep; 359():224-247. PubMed ID: 28754312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Representation of spontaneous movement by dopaminergic neurons is cell-type selective and disrupted in parkinsonism.
    Dodson PD; Dreyer JK; Jennings KA; Syed EC; Wade-Martins R; Cragg SJ; Bolam JP; Magill PJ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):E2180-8. PubMed ID: 27001837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
    Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK
    Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.